Misclassification problems in diagnosis-related groups. Cystic fibrosis as an example

Area of Science:

• Healthcare economics
• Medical classification systems
• Pulmonology

Background:

• The Medicare prospective payment system (PPS) utilizes diagnosis-related groups (DRGs) for reimbursement.
• Inappropriate DRG classification can lead to financial disparities and inadequate resource allocation.
• Cystic fibrosis (CF) presents unique resource utilization challenges within existing DRGs.

Purpose of the Study:

• To evaluate the accuracy of DRG classification for patients with cystic fibrosis.
• To compare resource utilization (length of stay, cost) between CF patients and other patients within the same DRGs.
• To identify potential solutions for improving DRG assignment for CF patients.

Main Methods:

• Analysis of discharge abstract data from 14 cystic fibrosis centers.
• Comparison of length of stay and treatment costs for 1763 CF patients versus 25,628 non-CF patients across 87 DRGs.
• Cost data conversion from charges for three hospitals.

Main Results:

• CF patients had significantly longer hospital stays (14.9 days vs. 8.3 days) and higher treatment costs ($7,262 vs. $2,908) compared to non-CF patients in the same DRGs (P < 0.001).
• The cost ratio (2.5) exceeded the length-of-stay ratio (1.8), indicating more intensive resource use by CF patients.
• These findings highlight significant under-reimbursement for CF care under the current DRG system.

Conclusions:

• Current DRG classifications inadequately capture the resource needs of cystic fibrosis patients.
• Revising the DRG system, potentially through new CF-specific DRGs or reclassification, is necessary.
• Improved classification will ensure equitable reimbursement and appropriate resource allocation for CF care.